SCHEMBL95571

SCHEMBL95571

CCCN(C)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756560 1.00
Hydrochloric Acid SCHEMBL6609957 0.97
SCHEMBL8279455 0.92
SCHEMBL4754736 0.92
SCHEMBL13745011 0.90 DRD2 (0.37)
SCHEMBL3372270 0.89 ADH1A (0.50)
Hydrochloric Acid SCHEMBL5379324 0.89 ADH1A (0.45)
SCHEMBL10102970 0.88 DRD2 (0.36)
SCHEMBL3273602 0.88 DRD2 (0.36)
SCHEMBL17046171 0.87 ADH1A (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102186803-A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors NOVARTIS AG 2011-09-14 CN claimed
WO-2005012297-A9 BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2007-01-04 WO claimed
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP claimed
EP-1660492-A1 BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS Janssen Pharmaceutica N.V. (BE) 2006-05-31 EP claimed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO claimed
WO-2005012297-A1 BENZIMIDAZOLE, BENZTHIAZOLE AND BENZOXAZOLE DERIVATIVES AND THEIR USE AS LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-10 WO claimed
EP-0870756-B1 Process for the preparation of 3,4-disubstituted dinitroanilines CFPI NUFARM (FR) 2001-11-07 EP claimed
US-6028226-A Process for 3,4-disubstituted dinitroanilines CFPI AGRO (FR) 2000-02-22 US claimed
US-5981800-A Preparation process for 4-substituted dinitroanilines CFPI AGRO (FR) 1999-11-09 US claimed
EP-0870756-A1 Process for the preparation of 3,4-disubstituted dinitroanilines CFPI AGRO (FR) 1998-10-14 EP claimed
EP-0870755-A1 Process for the preparation of 4-substituted nitroanilines CFPI AGRO (FR) 1998-10-14 EP claimed
US-4275238-A CYCLIZING BUTANEDIOL USING A COBALT CATALYST, ALKYLATING WITH PROPYLAMINE CIBA-GEIGY CORPORATION (US) 1981-06-23 US claimed
US-4264527-A REACTING CYCLOPROPYLMETHYLAMINE WITH PROPIONITRILE IN THE PRESENCE OF A HYDROGENATION CATALYST AND HYDROGEN CIBA-GEIGY CORPORATION (US) 1981-04-28 US claimed
WO-2024015055-A1 PYRAZOLO[3,4-D]PYRIMIDIN-6-YL-SULFONAMIDE DERIVATIVES FOR THE INHIBITION OF SGK-1 AND TREATMENT OF CANCER THRYV THERAPEUTICS INC. (CA) 2024-01-18 WO disclosed
US-11426399-B2 Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase ALKAHEST, INC. (US) 2022-08-30 US disclosed
US-20220226304-A1 Treatment of Aging-Associated Disease with Modulators of Leukotriene A4 Hydrolase ALKAHEST, INC. 2022-07-21 US disclosed
US-4264527-A REACTING CYCLOPROPYLMETHYLAMINE WITH PROPIONITRILE IN THE PRESENCE OF A HYDROGENATION CATALYST AND HYDROGEN CIBA-GEIGY CORPORATION (US) 1981-04-28 US disclosed
US-4264527-A REACTING CYCLOPROPYLMETHYLAMINE WITH PROPIONITRILE IN THE PRESENCE OF A HYDROGENATION CATALYST AND HYDROGEN CIBA-GEIGY CORPORATION (US) 1981-04-28 US disclosed
US-4264527-A REACTING CYCLOPROPYLMETHYLAMINE WITH PROPIONITRILE IN THE PRESENCE OF A HYDROGENATION CATALYST AND HYDROGEN CIBA-GEIGY CORPORATION (US) 1981-04-28 US disclosed
US-4205009-A USING ANIONIC SURFACTANT VELSICOL CHEMICAL CORPORATION (US) 1980-05-27 US disclosed